Chet Metcalf
Vice President - Research & Development Chemistry Regeneron Pharmaceuticals
Seminars
Monday 12th October 2026
Summary Panel Discussion: Discussing the Future of ADC Chemistry & Design to Herald a New Era of Bioconjugate Innovation
3:00 pm
At the end of the seminar day, don’t miss this summary panel discussion to discuss, debate and challenge your speakers and ADC peers on the cutting-edge of ADC design, exploring the most promising areas of ADC innovation, benefits against traditional therapies, and hurdles to advance novel conjugates into and through the clinic.
Monday 12th October 2026
Spotlighting Discovery of Novel Linker Payloads to Set the Path for the Next Wave of Differentiated Antibody Conjugates
12:30 pm
- Breaking down discovery and lessons learned from REGN5093 (METxMET)-M114 biparatopic ADC
- Exploring the Regeneron ProDXd platform for discovery and development of differentiated ADCs
- Assessing novelty and discovery ot targeting GPCRs with Antibody Tethered Ligand (ATL) conjugates
Monday 12th October 2026
Pushing the Boundary of Novel Bioconjugate Mechanisms & Design
